We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Misleading Advertisements Land Two Drugmakers FDA Warning Letters
Misleading Advertisements Land Two Drugmakers FDA Warning Letters
The FDA’s Office of Prescription Drug Promotion (OPDP) issued warning letters to two companies for publishing misleading advertisements that omitted risks and exaggerated benefits.